The Effect of Angiotensin Receptor-Neprilysin Inhibitor With Sodium-Glucose Cotransporter 2 Inhibitor versus Angiotensin Receptor-Neprilysin Inhibitor Without Sodium-Glucose Cotransporter 2 Inhibitor on Heart Failure Outcomes in Patients With Heart Failure With Reduced Ejection Fraction

被引：0
|
作者：
Kommu, Sharath
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Heart Failure; Angiotensin-Receptor Neprilysin Inhibitor (ARNI); Outcomes; Ejection fraction; Cardioprotective drugs;
D O I：
10.1161/circ.148.suppl_1.12247
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A12247
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The combination of angiotensin receptor-neprilysin inhibitor and sodium-glucose cotransporter-2 inhibitors in heart failure with reduced ejection fraction patients comorbid with diabetes mellitus
    Hsiao, F. C.
    Lin, C. P.
    Chang, P. C.
    Wang, C. L.
    Chu, P. H.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 1049 - 1049
  • [2] Effectiveness and safety of angiotensin receptor-neprilysin inhibitor and sodium-glucose cotransporter-2 inhibitors for patients with heart failure with reduced ejection fraction: a meta-analysis
    Huang, Yun
    Fang, Chongbo
    Zhang, YuYu
    Ma, Lili
    Zhou, Hua
    Ye, Honghua
    [J]. JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 (02) : 123 - 131
  • [3] Comparing angiotensin receptor-neprilysin inhibitors with sodium-glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus
    Tsai, Ming-Lung
    Lin, Yuan
    Lin, Ming-Shyan
    Tsai, Tzu-Hsien
    Yang, Ning-, I
    Wang, Chao-Yung
    Hsieh, I-Chang
    Hung, Ming-Jui
    Chen, Tien-Hsing
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [4] Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report
    Schumacher, Christine
    [J]. JOURNAL OF PHARMACY PRACTICE, 2024, 37 (02) : 495 - 499
  • [5] Benefits of Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure with Reduced Ejection Fraction: A Longitudinal Study
    Jain, Dharmendra
    Pandey, Umesh Kumar
    Tripathi, Suyash
    Kaushley, Abhishek
    Verma, Bhupendra
    Ghosh, Soumik
    Santosh, Krishna Vemuri
    Prajapati, Rajpal
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (04) : EC17 - EC22
  • [6] Association Between Use of Sodium-Glucose Cotransporter-2 Inhibitors or Angiotensin Receptor-Neprilysin Inhibitor and the Risk of Atherosclerotic Cardiovascular Disease With Coexisting Diabetes and Heart Failure
    Lin, Ya-Wen
    Lin, Chun-Hsiang
    Lin, Cheng-Li
    Lin, Che-Huei
    Lin, Ming-Hung
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2024, 29
  • [7] Effect of angiotensin receptor-neprilysin inhibitor treatment on erectile dysfunction in heart failure with a reduced ejection fraction
    Sert, Sena
    Karabay, Emre
    Gungor, Baris
    Yildirimturk, Ozlem
    [J]. MARMARA MEDICAL JOURNAL, 2023, 36 (01): : 99 - 104
  • [8] Combining sodium-glucose cotransporter 2 inhibitors and angiotensin receptor-neprilysin inhibitors in heart failure patients with reduced ejection fraction and diabetes mellitus: A multi-institutional study
    Hsiao, Fu-Chih
    Lin, Chia-Pin
    Tung, Ying-Chang
    Chang, Po-Cheng
    McMurray, John J., V
    Chu, Pao-Hsien
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 330 : 91 - 97
  • [9] Comparison between angiotensin receptor neprilysin inhibitor-first and sodium-glucose cotransporter 2 inhibitors-first strategies in patients with symptomatic heart failure and reduced ejection fraction
    Lee, W. Weichieh
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 61 - 61
  • [10] Clinical efficacy of angiotensin receptor-neprilysin inhibitor in de novo heart failure with reduced ejection fraction
    Park, Su Yeong
    Kong, Min Gyu
    Moon, Inki
    Park, Hyun Woo
    Choi, Hyung-Oh
    Seo, Hye Sun
    Cho, Yoon Haeng
    Lee, Nae-Hee
    Lee, Kwan Yong
    Jang, Ho-Jun
    Kim, Je Sang
    Choi, Ik Jun
    Suh, Jon
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (05): : 692 - 703
12345